GLP-1 receptor agonists have demonstrated consistent reductions in major adverse cardiovascular events in large cardiovascular outcome trials involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease
GLP1 at the MetabolicCognitive Interface: Reward, Affect, and Memory
By incorporating Intermittent Fasting into your routine, you might experience these health benefits
Under extreme heat stress, cells produce a large amount of ROS, leading to oxidative stress and protein misfolding in the ER, resulting in ER stress and triggering ChaC1-associated UPR
Can BPC-157 cause anxiety along with insomnia
Inflammation 37:18371846 Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, Haghikia A, Li XS, Wu Y, Saha PP et al (2023) The artificial sweetener erythritol and cardiovascular event risk